CST3 and acute kidney injury: Earlier detection of AKI by plasma cystatin C or urine NGAL in decompensated cirrhotic patients may have a huge impact on patient outcome if it leads to individually tailored therapy including more intensive monitoring of volume status and avoidance of nephrotoxic drugs such as aminoglycosides, diuretics or radio-contrast agents.